Invictus and Breakthrough T1D Partner on First-in-Human Insulin Trial
Breakthrough T1D award will fund project to advance fully automated insulin delivery Invictus Therapeutics, a biotechnology company developing next-generation insulin analogs engineered for automated insulin...
